Advocating for Impact: ASHP on PBMs Part 3: White Bagging and Site of Care Restrictions

This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. 

In this episode, we look at how insurers leverage practices restricting acquisition and administration of infused medications to steer patients towards insurer-owned providers and explore how these policies impact pharmacists, patients, and overall quality of care. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.